Posit Science Corporation
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Posit Science Corporation sits in the top decile of US sponsors by registered trial count (#538 of 15,742 sponsors by registered trial count).
Posit Science Corporation: 30 sponsored US clinical trials, none currently recruiting.
Posit Science Corporation sponsors 30 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 29 completed. 0 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Age-related Cognitive Decline, with 2 trials.
Top-decile sponsor footprint
Posit Science Corporation ranks in the top decile of sponsors by registered trial count (#538 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
29 of 29 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
30 total, page 1 of 1
Remote STATE Training for Insomnia in Older Adults
NCT06589024
Brain Enhancement Training Towards Elders Resilience to Aging, Phase IIB
NCT05599490
Community-based Brain Health Program to Address Dementia Risk
NCT05529706
Remote Digital Health Intervention to Improve Balance and Reduce Fall Risk
NCT05022589
Care Improving Cognition for ADolescents on the Autism Spectrum
NCT04562688
Wiring Adolescents With Social Anxiety Via Behavioral Interventions
NCT03990870
HeartMapp: Assessment and Treatment for Heart Failure
NCT03827954
STATE Trial: SusTained Attention Training to Enhance Sleep - Remote
NCT03604380
Brain Enhancement Training Towards Elders Resilience to Aging
NCT03197454
CCTAP: Cognitive Control Training for Treatment of AUD-PTSD
NCT03200028
Creating Live Interactions to Mitigate Barriers
NCT03317769
A Closed-loop Assessment and Treatment Platform for Unipolar Depression and Anxiety
NCT02948036
Home-Based, Online, Mindfulness and Cognitive Training for Soldiers and Veterans With TBI
NCT02922569
STATE Trial: SusTained Attention Training to Enhance Sleep
NCT02921074
Cognitive Remediation for HIV-associated Neurocognitive Dysfunction
NCT02671526
Attention Training for Learning Enhancement and Resilience Trial
NCT02416401
Piloting a Novel, Mobile Cognitive Training Tool for Patients With Major Depressive Disorder (MDD)
NCT02922556
Plasticity-based Adaptive Cognitive Remediation for Alzheimer Disease
NCT02331784
Treatment of Social Cognition in Schizophrenia Trial
NCT02246426
Broad-spectrum Cognitive Remediation: Effects of a Brain Plasticity-based Program in Mild Traumatic Brain Injury
NCT01640158
Remediation of Spatial Neglect Trial
NCT01965951
Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia
NCT01773239
Evaluation of a Cognitive Adaptive E-treatment in Schizophrenia-diagnosed Adults
NCT01422902
Computerized Attention Training for Individuals With Acquired Brain Injury
NCT01641432
Computer-Based Training in Patients With Post-Chemotherapy Cognitive Impairment
NCT00387062
Improvement in Memory With Plasticity-Based Adaptive Cognitive Training (IMPACT)
NCT00283010
Computer-Based Training for Cognitive Enhancement: Classroom Study
NCT00337909
Computer-Based Training for Cognitive Enhancement: In Home Study
NCT00337974
Computer-Based Training for Mild Alzheimer's Disease
NCT00319891
Computer-Based Therapy for Mild Cognitive Impairment
NCT00319943
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 1 |
Therapeutic Areas
How the Posit Science Corporation early-phase archive is shaped
30 indexed studies, none listed as recruiting (0% open); 29 completed (97%).
Phase mix: 0 late (III/IV) vs 5 early (I/II) (early-phase heavy).
Top condition: Age-related Cognitive Decline (2 trials), 9 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Posit Science Corporation: archived-pipeline peers nationwide
Peers matched on 30 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Posit Science Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 30 archived trials
- Biotronik · 30 trials · 3% recruiting
- Charles Drew University of Medicine and Science · 30 trials · 3% recruiting
- Chiesi Farmaceutici S.p.A. · 30 trials · 13% recruiting
- Debiopharm International · 30 trials · 17% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Posit Science Corporation page
30 registered trials is a research-attention snapshot, not an endorsement of Posit Science Corporation or any single study.
- None of Posit Science Corporation's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Age-related Cognitive Decline is the condition Posit Science Corporation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Age-related Cognitive Decline trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Posit Science Corporation pipeline card: 30 registered trials from official public datasets.Report a data error.